← Eichor
Condition: Infection Hip Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Infection Hip

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluating XPERIENCE™ Advanced Surgical Irrigation
NA · 8 location(s) · Ottawa Hospital Research Institute · NCT05543941Long Term Follow-up of Patients With Prosthetic Joint Infection of the Hip Treated at University Hospitals Leuven
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT05000723Periprosthetic Joint Infections: Diagnostic Accuracy and Cost-effectiveness Analysis of Serum and Synovial Markers
Phase N/A · 1 location(s) · Istituto Ortopedico Rizzoli · NCT04858217The Effect of Peri-Operative Adjunctive Probiotics on Immunological Markers in Cases of Prosthetic Joint Infection of th
NA · 1 location(s) · NYU Langone Health · NCT06919913Pre- and Postoperative Chest Therapy With Positive Expiratory Pressure (PEP) to Prevent Hospital-acquired Pneumonia
NA · 2 location(s) · University Hospital Bispebjerg and Frederiksberg · NCT07189260ROADMAP Clinical Trial
Phase 4 · 43 location(s) · University of Newcastle, Australia · NCT06771050Prediction of Mortality and Morbidity After Hip Fracture Using Monocyte Distribution Width (MDW)
Phase N/A · 1 location(s) · National and Kapodistrian University of Athens · NCT07350785SHort Interval Full Two-stage Implant Exchange
NA · 2 location(s) · University Hospital, Montpellier · NCT05642013Wound Healing, Dressing Type, and Dressing Change Frequency in THA
NA · 1 location(s) · Clinical Center of Vojvodina · NCT07655388Wound Closure Materials and Techniques in Hip and Knee Arthroplasty
NA · 1 location(s) · Bahattin Kemah · NCT07439575Investigating Periprosthetic Fracture Cultures in Arthroplasty
Phase N/A · 1 location(s) · University of Chicago · NCT06952738Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Revision Hip Prosthesis System
Phase N/A · 4 location(s) · TIPMED Medical Device Manufacturing Ltd. Co. · NCT07653295Swiss Revision Cohort
Phase N/A · 5 location(s) · Insel Gruppe AG, University Hospital Bern · NCT07473089Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement.
Phase 2 · 1 location(s) · University Hospital, Linkoeping · NCT05169229Preoperative Fasting and the Gut Microbiome Before Hip Replacement
NA · 1 location(s) · Charite University, Berlin, Germany · NCT07651462Analysis of Pharmacological Aspects Regarding Infection Free Survival After Surgical Treatment of a Periprosthetic Hip I
Phase N/A · 1 location(s) · University Hospital, Bonn · NCT07299591Innovative Technologies for Salvage Procedures of Failed Treatments of Osteoarthritis: Biomimetics Solutions (CustomPN)
Phase N/A · 1 location(s) · Istituto Ortopedico Rizzoli · NCT06527664Clinical Evaluation and Cost-effectiveness Analysis of 3D Digital Surgery in Traumatology
NA · 1 location(s) · Corporacion Parc Tauli · NCT06603831CLinical Evaluation of ANtiseptic Skin Preparation in Revision Total Joint Arthroplasty of the Hip and Knee
NA · 3 location(s) · Sunnybrook Health Sciences Centre · NCT05828810IP-coated Revision Hip Implants
NA · 2 location(s) · Aesculap AG · NCT06737809Efficacy of New Silver-coated Prosthesis in Reducing the Incidence of Periprosthetic Infections
Phase N/A · 2 location(s) · Istituto Ortopedico Rizzoli · NCT06887816Rifampicin Combination Therapy Versus Monotherapy for Staphylococcal Prosthetic Joint Infection
Phase 4 · 13 location(s) · Leiden University Medical Center · NCT06172010
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.